Chemical industry – Page 61
-
BusinessSanofi and Merck & Co end vaccines partnership
Two-decade-long alliance will split by end of 2016
-
BusinessExxonMobil sued for Clean Air Act violations
Environmental campaigners claim ExxonMobil’s plant emissions harm local residents
-
BusinessDow to settle polyurethane price-fixing case
Chemical giant cancels Supreme Court appeal of damages and agrees $835m settlement
-
Business
EPA aims to remove flubendiamide pesticide from market
After reassessing environmental impact, the agency wants to withdraw Bayer and Nichino America insecticides
-
OpinionForged in righteous flames
Could the debate over pharma price-gouging have positive results for both patients and companies?
-
BusinessQuotient ups carbon-14 quota with recycling plant
Plant may provide a solution to the supply shortage of the radiolabel barium [C-14] carbonate
-
Business
Illumina to sue Oxford Nanopore over patent infringement
UK firm’s use of pore proteins in DNA sequencing alleged to contravene two Illumina patents
-
Business
BASF to cut 350 jobs in plant science research
Company will also close field trial sites in Hawaii, India and Puerto Rico
-
Business
Glyphosate persistence raises questions
Herbicide remains in water and soil longer than thought, but how that translates to human and environmental risk is unclear
-
OpinionRare earth magnates
China’s monopoly on production has a global impact, argues David Abraham
-
Business
Pfizer agrees potential $785m fraud settlement
Whistleblower case relates to claims of Wyeth overcharging for acid reflux drugs between 2001 and 2006
-
FeatureThe white stuff
With potential health concerns raised over nanosize forms of TiO2, Emma Davies explores the ubiquitous white pigment’s past, present and future
-
BusinessAkzoNobel to buy BASF’s industrial coatings
€475 million deal includes technology, products and sites in the UK and South Africa
-
ResearchIncredibly rare and unstable mineral shows catalytic clout
Georgeite shows promise as a catalyst precursor for the synthesis of methanol
-
Business
Lilly loses UK patent challenge
Allergan’s cancer drug generics do not infringe patents, say UK courts
-
Business
GSK fined for stalling antidepressant generics
UK Competition and Markets Authority deems pay-for-delay deal illegal and imposes £45m in fines
-
BusinessMylan to buy Meda in further generics consolidation
£6.9bn deal will give combined company ‘critical mass’ in US market
-
BusinessOil slump reverberates in chemicals
Collapse in crude prices has complex and mixed effects on markets for derivative chemicals
-
BusinessChemChina offers to buy Syngenta in $43bn takeover
Directors welcome deal that will allow agrochemicals giant to establish a presence in China
-
BusinessMedical devices consolidation continues
Abbott to buy Alere for $5.8bn to augment its point-of-care diagnostics business